What Does PrEP Really Cost in 2026? Daily Pills vs. 2-1-1 vs. Yeztugo

Key takeaways

• The sticker price is not the same as your out-of-pocket cost. Under most U.S. health plans, PrEP medication, required visits and laboratory monitoring may be covered without cost sharing.
• Daily generic TDF/FTC is predictable: 365 tablets a year plus regular follow-up. A July 2026 coupon price for 30 generic tablets was about $28.65, but pharmacy prices change.
• 2-1-1 can reduce the number of tablets used, but it is an off-label option studied only in adult gay and bisexual men. It is not FDA-approved or recommended by CDC.
• Yeztugo has a first-year U.S. list price of $30,569.50 before other care, but eligible patients may pay much less—or potentially $0—through insurance or assistance.
• VaultCare Health Len Access may create a lower-cost Southeast Asia pathway once local approval and clinic supply are active. It is not a medication purchase, and savings depend on the final clinic and travel quote.

PrEP, in plain English

PrEP stands for pre-exposure prophylaxis. It is prescription medicine taken by people who do not have HIV to reduce their chance of acquiring HIV before a possible exposure. It is different from PEP, which is an emergency medication started after a recent exposure. PrEP prevents HIV—not gonorrhea, syphilis, chlamydia, HPV, herpes or other STIs.

The three options compared in this article are:

• Daily oral PrEP: One TDF/FTC tablet every day. It offers a simple, continuous routine and can be used across a broad range of exposure types when medically appropriate.
• 2-1-1 PrEP: TDF/FTC tablets are taken around planned sex instead of every day. This off-label approach has been studied only in adult gay and bisexual men and requires precise timing, so a clinician must confirm whether it is appropriate.
• Twice-yearly injectable PrEP: Lenacapavir, sold as Yeztugo in the United States, is given by a healthcare professional every six months after starter dosing. Each visit involves two subcutaneous injections, and HIV-negative status must be confirmed before starting and before subsequent doses.

All three options require medical assessment and follow-up. The best choice depends on your health, type and frequency of exposure, ability to follow the schedule, privacy needs and access to care.

Ask someone what PrEP costs and you may hear anything from “free” to “more than $30,000 a year.” Both answers can be true.

The problem is that most comparisons look only at the drug. Your real PrEP cost also includes HIV and STI testing, kidney monitoring, appointments, transportation, time away from work, insurance paperwork and the practical cost of staying on schedule.

Here is a more useful way to compare three common strategies in 2026.

The real-cost formula

Use this formula instead of comparing pharmacy prices alone:

Real annual PrEP cost = medication + testing + clinical care + administration + travel and time + adherence and privacy costs

The last category is not imaginary. A cheap prescription that repeatedly gets missed, exposes private health information at home or requires inconvenient appointments may not be the lowest-cost option in real life.

At a glance: three PrEP strategies

Strategy	Medication pattern	Typical clinical schedule	Main cost advantage	Main cost risk
Daily TDF/FTC	One tablet every day	Follow-up generally every 3 months	Predictable; inexpensive generic available	Paying for unused tablets or struggling with daily adherence
2-1-1 TDF/FTC	Event-driven tablets around planned sex	Regular testing still required	Fewer tablets when sex is infrequent and predictable	Complex timing; unsuitable for many people
Yeztugo (lenacapavir)	Two subcutaneous injections at one visit every 6 months, after starter dosing	HIV testing before initiation and each subsequent injection	Only two injection visits per year	High list price, prior authorization and travel or clinic access

PrEP reduces the risk of acquiring HIV from sex by about 99% when taken as prescribed, but it does not prevent syphilis, gonorrhea, chlamydia, HPV, herpes or other STIs. Testing, vaccination, condoms where appropriate and clinician follow-up remain part of the budget.

Option 1: daily generic TDF/FTC

Daily TDF/FTC—the generic equivalent of Truvada—is the easiest option to budget.

You need approximately 365 tablets for a full year. In July 2026, GoodRx displayed a coupon price of about $28.65 for 30 generic 200 mg/300 mg tablets at participating pharmacies. Prices vary by location, pharmacy, coupon and availability, so treat that figure as a snapshot rather than a guaranteed price.

At that example price:

• Medication alone: about $344 a year
• Plus: baseline testing and follow-up, generally every three months
• Plus: transportation, appointment time and any uncovered laboratory charges

For many insured Americans, the calculation may instead begin at $0 out of pocket. HIV.gov states that under almost all qualifying health plans, PrEP medication, clinic visits and required laboratory tests should be covered without copays or coinsurance. Network rules, billing codes and formulary decisions can still create friction, so confirm coverage before the first prescription.

Daily PrEP usually makes financial and practical sense when exposure is frequent or unpredictable, when vaginal protection is needed, or when a simple daily habit is easier than remembering an event-based sequence.

Option 2: 2-1-1 PrEP

For one isolated sexual event, the 2-1-1 schedule uses four TDF/FTC tablets:

1. Two tablets 2–24 hours before sex
2. One tablet 24 hours after the first dose
3. One tablet 48 hours after the first dose

If sex continues on consecutive days, dosing continues and the total is no longer simply four tablets per encounter.

Medical note: This is general education, not individualized dosing advice. Do not start or switch to 2-1-1 without a qualified clinician confirming that it is appropriate for you.

CDC says 2-1-1 may be prescribed off-label to adult gay and bisexual men who have sex infrequently—such as less than once a week—and can anticipate sex at least two hours in advance. It is not FDA-approved or recommended by CDC, has not been adequately studied for vaginal exposure, and should be avoided in people with active hepatitis B because episodic TDF/FTC use can cause liver complications.

The medication math can still be useful:

• Two isolated events per month: about 96 tablets a year
• Four isolated events per month: about 192 tablets a year
• Daily PrEP: about 365 tablets a year

At $0.96 per tablet—the approximate per-tablet value of the $28.65 coupon example—the medication portion would be roughly $92 or $184 in the first two scenarios.

That does not eliminate regular HIV testing, STI screening or clinical care. If testing is your largest uncovered expense, cutting the tablet count may produce less savings than expected.

Option 3: twice-yearly Yeztugo

Yeztugo is the U.S. PrEP brand of lenacapavir. It is administered by a healthcare professional every six months, with two subcutaneous injections at each visit. Starting treatment also includes oral doses on the first two days.

Gilead’s published price information lists:

• Injectable component: $28,218 per year
• First-year oral initiation component: $2,351.50
• First-year list price: $30,569.50, before administration, testing or other care

That is a list price—not necessarily what a patient pays. Gilead says eligible commercially insured patients may pay as little as $0 through its assistance program. HIV.gov also notes that most qualifying U.S. health plans should cover FDA-approved PrEP and related preventive services without patient cost sharing.

The less visible costs are different from those of pills:

• Prior authorization and specialty-pharmacy coordination
• HIV testing before initiation and before each subsequent injection
• Keeping the six-month appointment on time
• Injection-site reactions
• A clinician-managed transition plan if injections are delayed or stopped

Yeztugo may be worth considering when daily adherence, pill storage or privacy is a bigger burden than attending two planned visits per year.

Can Southeast Asia lower the cost of lenacapavir?

Potentially—but only when comparing complete, legally available pathways.

For someone facing the full U.S. cash price, an authorized Southeast Asia clinic price could eventually be substantially lower. It should not be compared with an insured U.S. patient whose out-of-pocket cost is $0.

VaultCare Health’s current public prices are:

• International membership: $29 per month or $319 per year
• Len Access: $99 per injection cycle
• Two cycles plus annual membership: $517 per year in platform fees

Len Access is a digital queue and care-coordination service. The $517 illustration does not include the medication, clinic consultation, HIV testing, injection administration, airfare, hotel, local transportation or time away from work.

Use this formula after receiving a written clinic quote:

Southeast Asia total = $319 membership + (2 × $99 Len Access) + two clinic-cycle quotes + two trips

Potential first-year saving = $30,569.50 U.S. list price − Southeast Asia total

As of July 16, 2026, Gilead reports that lenacapavir PrEP applications submitted in Thailand and Vietnam remain under regulatory review. VaultCare Health can coordinate access only after lawful local availability and partner-clinic supply are confirmed. A queue position is not a guaranteed injection appointment.

Gilead also expects licensed generic lenacapavir to reach approximately $40 per person per year in eligible lower-income markets beginning in 2027, after regulatory approval. That is an access-program production target—not a 2026 retail price or a guaranteed price for medical travelers.

Which option offers the best value?

Choose based on the cost you will actually bear:

• Insured in the United States: Verify $0 PrEP coverage first. Domestic care may be financially cheapest.
• Uninsured with frequent or unpredictable exposure: Daily generic TDF/FTC usually offers the most predictable cash budget.
• Eligible for 2-1-1 with infrequent, planned sex: It may reduce medication spending, but testing and clinical costs remain.
• Daily adherence or privacy is the main obstacle: Twice-yearly lenacapavir may justify a higher financial or travel cost.
• Considering cross-border access: Compare a written all-in clinic and travel quote against your actual U.S. out-of-pocket cost—not against a headline price alone.

The cheapest PrEP is not automatically the option with the lowest pharmacy receipt. It is the medically appropriate option you can obtain legally, monitor safely and follow reliably.

Sources and medical disclaimer

This article is educational and does not replace an individual assessment, prescription or monitoring plan. Confirm HIV-negative status and discuss kidney function, hepatitis B, other medicines, pregnancy considerations and follow-up testing with a qualified healthcare professional before starting or changing PrEP.

• CDC Clinical Guidance for PrEP
• HIV.gov: PrEP options, follow-up and insurance coverage
• FDA prescribing information for Yeztugo
• Gilead Yeztugo cost information
• Gilead global access and regulatory progress
• GoodRx generic TDF/FTC price reference
• VaultCare Health pricing